In solid tumors, particularly HR+/HER2- and triple-negative breast cancers (suffering from a prevalence of > 90%), Trop-2 is a transmembrane calcium signal transducer that is associated with tumor progression and prognosis (21, 22). The gene discussed is TACSTD2; the disease is neoplasm.